Trials / Conditions / Castrate-resistant Prostate Cancer (CRPC)
Castrate-resistant Prostate Cancer (CRPC)
4 registered clinical trials studyying Castrate-resistant Prostate Cancer (CRPC).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prosta NCT03690141 | Effector Therapeutics | Phase 2 |
| Terminated | Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy NCT01450683 | Stanford University | Phase 2 |
| Terminated | Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer NCT01020305 | Sandy Srinivas | Phase 1 / Phase 2 |
| Completed | MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer NCT00868595 | Bellicum Pharmaceuticals | Phase 1 |